Journal article

Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors

DG Pellicci, O Patel, L Kjer-Nielsen, SS Pang, LC Sullivan, K Kyparissoudis, AG Brooks, HH Reid, S Gras, IS Lucet, R Koh, MJ Smyth, T Mallevaey, JL Matsuda, L Gapin, J McCluskey, DI Godfrey, J Rossjohn

Immunity | CELL PRESS | Published : 2009

Abstract

The semi-invariant natural killer T cell receptor (NKT TCR) recognizes CD1d-lipid antigens. Although the TCRα chain is typically invariant, the β chain expression is more diverse, where three Vβ chains are commonly expressed in mice. We report the structures of Vα14-Vβ8.2 and Vα14-Vβ7 NKT TCRs in complex with CD1d-α-galactosylceramide (α-GalCer) and the 2.5 Å structure of the human NKT TCR-CD1d-α-GalCer complex. Both Vβ8.2 and Vβ7 NKT TCRs and the human NKT TCR ligated CD1d-α-GalCer in a similar manner, highlighting the evolutionarily conserved interaction. However, differences within the Vβ domains of the Vβ8.2 and Vβ7 NKT TCR-CD1d complexes resulted in altered TCRβ-CD1d-mediated contacts a..

View full abstract

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

We thank the staff at the Australian synchrotron and the Advance Photon Source (Chicago, IQ for assistance with data collection. The Australian Research Council (ARC), the National Health and Medical Research Council of Australia (NHMRC), and the Cancer Council of Victoria supported this research. L.G. was supported by an NIH grant (AI057485). D.I.G. and M.J.S. are supported by NHMRC Research Fellowships. J.R. is supported by an ARC Federation Fellowship.